Scarica l'app Stockscreener
2.545
3.58%
-0.105
Dopo l'orario di chiusura:
2.58
0.035
+1.38%
Precedente Chiudi:
$2.65
Aprire:
$2.67
Volume 24 ore:
742.53K
Relative Volume:
1.25
Capitalizzazione di mercato:
$368.96M
Reddito:
$18.67M
Utile/perdita netta:
$-64.78M
Rapporto P/E:
-4.4115
EPS:
-0.5769
Flusso di cassa netto:
$-37.02M
1 W Prestazione:
+7.81%
1M Prestazione:
+75.00%
6M Prestazione:
+37.37%
1 anno Prestazione:
+85.14%
Intervallo 1D:
$2.47
$2.68
Intervallo di 1 settimana:
$2.40
$2.73
Portata 52W:
$1.22
$2.73
Omniab Inc Stock (OABI) Company Profile
Nome
Omniab Inc
Settore
Industria
Telefono
510-250-7800
Indirizzo
5980 HORTON STREET, EMERYVILLE
Compare OABI vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OABI
Omniab Inc
|
2.545 | 384.18M | 18.67M | -64.78M | -37.02M | -0.5769 |
VRTX
Vertex Pharmaceuticals Inc
|
435.92 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.42 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.61 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Omniab Inc Stock (OABI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-11-29 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-04-21 | Iniziato | The Benchmark Company | Buy |
| 2023-04-13 | Iniziato | Craig Hallum | Buy |
| 2023-02-22 | Iniziato | Cowen | Outperform |
| 2023-02-13 | Iniziato | H.C. Wainwright | Buy |
| 2022-12-20 | Iniziato | Truist | Buy |
| 2022-12-16 | Iniziato | Credit Suisse | Outperform |
| 2022-11-29 | Iniziato | SVB Leerink | Outperform |
| 2022-11-28 | Iniziato | Stifel | Buy |
Mostra tutto
Omniab Inc Borsa (OABI) Ultime notizie
OmniAb Stock Is Back Near Its High — Why OABI’s Next Few Days Matter - Bez Kabli
OmniAb, Inc. Hits New 52-Week High at USD 2.73 - Markets Mojo
OmniAb Inc. (OABI) Shares Edge Higher as Key Support HoldsSocial Investment Platform - Newser
OmniAb Inc. (OABI) Rallies 3.9% as Stock Tests Key Resistance LevelsExpert Entry Points - Newser
Is OmniAb Positioned To Be A Long-Term Biotech Winner? - RTTNews
OmniAb, Inc. Common Stock OABI ) Stock Price Today & Analysis - Gotrade
OmniAb unveils OmniUltra in vivo platform at TIDES USA event - Traders Union
OmniAb, Inc. (OABI) reports Q1 loss, tops revenue estimates - MSN
We're Hopeful That OmniAb (NASDAQ:OABI) Will Use Its Cash Wisely - Moomoo
TradingKey - TradingKey
OmniAb forecasts $28M-$33M 2026 revenue as partner milestones lift outlook - MSN
OmniAb, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:OABI) 2026-05-11 - Seeking Alpha
Number of shareholders of OmniAb, Inc. – NASDAQ:OABIW - TradingView
OmniAb (NASDAQ:OABI) Issues Earnings Results - MarketBeat
OmniAb Reports Strong Revenue Growth Driven by Clinical Partner Progress - HarianBasis.co
OmniAb, Inc. (NASDAQ:OABI) Q1 2026 Earnings Call Transcript - Insider Monkey
OmniAb (OABI) FY 2025 Loss Of US$64.8m Keeps Profitability Narrative Under Pressure - Sahm
OmniAb Earnings Call Highlights Surge In Milestones - TipRanks
OmniAb’s Q1 2026 Revenue Rises to $25.3 Million, Net Loss Decreases - geneonline.com
OmniAb unveils in vivo platform for human antibody and peptide discovery at 2026 PEGS Summit - Traders Union
OmniAb (OABI) Q1 2026 Earnings Transcript - AOL.com
Craig-Hallum Maintains OmniAb(OABI.US) With Buy Rating, Announces Target Price $7 - Moomoo
OmniAb, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
OmniAb Q1 2026 slides: revenue surges 243%, guidance raised By Investing.com - Investing.com Australia
OmniAb Q1 Earnings Call Highlights - MarketBeat
TD Cowen Maintains OmniAb(OABI.US) With Buy Rating, Maintains Target Price $3 - Moomoo
H.C. Wainwright Maintains OmniAb(OABI.US) With Buy Rating, Maintains Target Price $11 - Moomoo
The organic vs inorganic growth story at OmniAb (OABI) | Q1 2026: EPS Beats ForecastsAI Stock Signals - newser.com
OmniAb Reports First Quarter 2026 Financial Results and Business Highlights - BioSpace
OmniAb, Inc. (OABI) Reports Q1 Loss, Tops Revenue Estimates - Yahoo! Finance Canada
Earnings call transcript: OmniAb Q1 2026 sees revenue surge, stock climbs - Investing.com
OmniAb Q1 2026 slides: revenue surges 243%, guidance raised - Investing.com India
Earnings call transcript: OmniAb Q1 2026 sees revenue surge, stock climbs By Investing.com - Investing.com South Africa
OmniAb (NASDAQ:OABI) Surges on Q1 Beat and Raised 2026 Guidance - ChartMill
OmniAb : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) - marketscreener.com
OmniAb : 1Q26 Earnings Presentation - marketscreener.com
OmniAb to Participate in Two Investor Conferences in November - Quantisnow
OmniAb, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
OmniAb has 107 partners and 409 programs — and just raised guidance - Stock Titan
OABI: Revenue surged and losses narrowed in Q1 2026, prompting an upward revision to full-year guidance - TradingView
OmniAb Inc expected to post a loss of 10 cents a shareEarnings Preview - TradingView
Omniab Inc Azioni (OABI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Omniab Inc Azioni (OABI) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| FOEHR MATTHEW W | President and CEO |
Apr 07 '26 |
Option Exercise |
0.00 |
36,459 |
0 |
4,439,736 |
| FOEHR MATTHEW W | President and CEO |
Apr 07 '26 |
Sale |
1.49 |
19,244 |
28,674 |
4,420,492 |
1.49%
0.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):